Medicine

Vera Nilsén, Julia Bojstedt, Johan E. A. Nordström

2026.1.22Frontiers in Transplantation

DOI: 10.3389/frtra.2026.1737352

tlooto Summary

SPK transplantation may be feasible in carefully selected patients with MELAS, ESRD, and diabetes, providing durable renal and metabolic graft function at 5 years, the first reported SPK case in MELAS, with extended follow-up.

Abstract

Background Mitochondrial encephalomyopathy with lactic acidosis, and stroke-like episodes (MELAS) is a rare mitochondrial DNA disorder that, in severe cases, can result in insulin-dependent diabetes and end-stage renal disease (ESRD). While organ transplantation is a potential treatment, documented cases remain scarce. Methods A 40-year-old patient with dialysis-dependent ESRD and diabetes secondary to MELAS underwent simultaneous pancreas-kidney transplantation. The perioperative and postoperative periods were uncomplicated with only targeted MELAS-specific adaptations to standard protocols. Results During the 5-year follow-up, the patient maintained excellent kidney allograft function and sustained insulin independence, with no need for dialysis or exogenous insulin therapy. At 5 years, creatinine was 77 µmol/L with an estimated GFR above 90 mL/min/1.73 m2, and glycated hemoglobin was 40 mmol/mol. Conclusions SPK transplantation may be feasible in carefully selected patients with MELAS, ESRD, and diabetes, providing durable renal and metabolic graft function at 5 years. To our knowledge, this is the first reported SPK case in MELAS, with extended follow-up.

Citation format

NILSÉN, Vera; BOJSTEDT, Julia; NORDSTRÖM, Johan E. A. Case report: Simultaneous pancreas–kidney transplantation in MELAS: First reported case with 5-year follow-up. Frontiers in Transplantation, 2026, 5: 1737352.